Title |
Shaping the cellular landscape with Set2/SETD2 methylation
|
---|---|
Published in |
Cellular and Molecular Life Sciences, April 2017
|
DOI | 10.1007/s00018-017-2517-x |
Pubmed ID | |
Authors |
Stephen L. McDaniel, Brian D. Strahl |
Abstract |
Chromatin structure is a major barrier to gene transcription that must be disrupted and re-set during each round of transcription. Central to this process is the Set2/SETD2 methyltransferase that mediates co-transcriptional methylation to histone H3 at lysine 36 (H3K36me). Studies reveal that H3K36me not only prevents inappropriate transcriptional initiation from arising within gene bodies, but that it has other conserved functions that include the repair of damaged DNA and regulation of pre-mRNA splicing. Consistent with the importance of Set2/SETD2 in chromatin biology, mutations of SETD2, or mutations at or near H3K36 in H3.3, have recently been found to underlie cancer development. This review will summarize the latest insights into the functions of Set2/SETD2 in genome regulation and cancer development. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
Austria | 1 | <1% |
Unknown | 149 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 49 | 32% |
Researcher | 17 | 11% |
Student > Master | 15 | 10% |
Student > Bachelor | 8 | 5% |
Student > Doctoral Student | 7 | 5% |
Other | 20 | 13% |
Unknown | 35 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 70 | 46% |
Agricultural and Biological Sciences | 29 | 19% |
Medicine and Dentistry | 7 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 2% |
Immunology and Microbiology | 2 | 1% |
Other | 4 | 3% |
Unknown | 36 | 24% |